FDA gets clear pet food authority—but relies on industry-led standards

What it does

This bill clarifies the FDA's authority to regulate pet food labels, labeling, and advertising nationwide, and requires the FDA to issue guidance on pet food nutritional standards, testing protocols, and ingredient safety within 18 months based on 2024 AAFCO standards. It delegates pet food oversight to the FDA's Center for Veterinary Medicine and mandates the agency issue proposed regulations within one year and final rules within two years, incorporating model regulations from the Association of American Feed Control Officials.

Why we flagged it

The bill's core function is to establish uniform federal pet food regulation and delegate oversight authority to a specific FDA center, with mandatory timelines for guidance and rulemaking. It is a regulatory modernization and clarification measure, not a deregulation or industry carve-out.

What the text implies

• Delegation to Center for Veterinary Medicine may concentrate pet food authority in a single FDA division, potentially creating a bottleneck if the center lacks resources to meet 18-month and 2-year deadlines.
• Reliance on 2024 AAFCO standards (a private, industry-led organization) as the basis for federal guidance and regulations may embed industry preferences into federal law without explicit congressional debate of those standards.
• Annual reporting requirement to Congress on performance metrics creates accountability, but failure to meet timelines carries no stated enforcement mechanism or penalty.
• Uniform national standards may preempt stricter state pet food rules, potentially reducing consumer choice in states that had adopted higher safety thresholds.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Pet owners and their animals benefit from clearer, uniform federal standards for pet food safety and labeling, reducing confusion from conflicting state rules and improving transparency about nutritional content and ingredient safety. The bill strengthens FDA oversight and accountability through mandatory reporting and science-based review processes.

Who stands to gain

• Pet food manufacturers (reduced compliance burden from state-by-state variation)
• Large pet food companies with resources to navigate federal rulemaking (relative advantage over smal

Named in the bill

FDA (Food and Drug Administration), Center for Veterinary Medicine (CVM), AAFCO (Association of American Feed Control Officials), HHS (Department of Health and Human Services), Bristol Myers Squibb (BMY), Genuine Health (GH), Pfizer (PFE), DaVita (DVA), Johnson & Johnson (JNJ)

Where it stands

15 cosponsors: 11 Republicans, 4 Democrats.

• Jan 21, 2025 — Introduced · Congress.gov: “Introduced in House”
• Jan 21, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

5 lobbying clients named this bill on 8 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $1,134,422 in lobbying spend. A filing names 9 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 78% of bills with at least one filing.

Steve Womack, the sponsor, reported $925,850 in PAC receipts in the 2026 cycle.

• General Mills Services Inc. (fka General Mills) — $670,000 on 2 filings
• American Veterinary Medical Association — $214,422 on 1 filing
• Pet Food Institute — $150,000 on 1 filing
• American Feed Industry Association (afia) — $100,000 on 2 filings
• Pet Industry Joint Advisory Council — $0 on 2 filings

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.